Researchers from the Perelman School of Medicine successfully modified the T cells of 12 HIV patients to resist infection. Here, a technician removes a case of modified cells from storage in an ultra-low temperature freezer for final testing prior to infusion.

Two technicians in Penn Medicine’s Clinical Cell and Vaccine Production Facility hold up a bag of modified T cells genetically edited to resist HIV infection.